Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
about
Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruziAnti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.Phenotypic screening approaches for Chagas disease drug discovery.3-pyridyl inhibitors with novel activity against Trypanosoma cruzi reveal in vitro profiles can aid prediction of putative cytochrome P450 inhibition.
P2860
Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Development of a Fluorescence- ...... Programmes for Chagas Disease
@ast
Development of a Fluorescence- ...... Programmes for Chagas Disease
@en
Development of a Fluorescence- ...... Programmes for Chagas Disease
@nl
type
label
Development of a Fluorescence- ...... Programmes for Chagas Disease
@ast
Development of a Fluorescence- ...... Programmes for Chagas Disease
@en
Development of a Fluorescence- ...... Programmes for Chagas Disease
@nl
prefLabel
Development of a Fluorescence- ...... Programmes for Chagas Disease
@ast
Development of a Fluorescence- ...... Programmes for Chagas Disease
@en
Development of a Fluorescence- ...... Programmes for Chagas Disease
@nl
P2093
P2860
P921
P3181
P1476
Development of a Fluorescence- ...... Programmes for Chagas Disease
@en
P2093
David Calvo
Ivan Caballero
Jennifer Riley
Kevin D Read
Michael Voice
P2860
P304
P3181
P356
10.1371/JOURNAL.PNTD.0004014
P407
P577
2015-09-01T00:00:00Z